Hap Trading, LLC Adaptimmune Therapeutics PLC Transaction History
Hap Trading, LLC
- $935 Billion
- Q1 2025
A detailed history of Hap Trading, LLC transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Hap Trading, LLC holds 15,100 shares of ADAP stock, worth $3,624. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,100Holding current value
$3,624% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ADAP
# of Institutions
74Shares Held
114MCall Options Held
77.5KPut Options Held
14.2K-
Eco R1 Capital, LLC San Francisco, CA27.4MShares$6.58 Million0.43% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR23.8MShares$5.7 Million0.16% of portfolio
-
Two Seas Capital LP Rye, NY20.5MShares$4.93 Million0.15% of portfolio
-
Nea Management Company, LLC Timonium, MD17.1MShares$4.1 Million0.32% of portfolio
-
Mpm Asset Management LLC Cambridge, MA5.34MShares$1.28 Million1.54% of portfolio
About Adaptimmune Therapeutics PLC
- Ticker ADAP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 163,370,000
- Market Cap $39.2M
- Description
- Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...